Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Stage 0-III Melanoma
Status: | Active, not recruiting |
---|---|
Conditions: | Skin Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/9/2018 |
Start Date: | March 13, 2017 |
End Date: | January 2020 |
Internet Intervention for Sun Protection and Skin Self-check Behaviors
This clinical trial studies how well an interactive tailored website works in promoting sun
protection and skin self-check behaviors in patients with stage 0-III melanoma. An
internet-based program may help individuals to perform skin self-checks and engage in sun
protection behaviors.
protection and skin self-check behaviors in patients with stage 0-III melanoma. An
internet-based program may help individuals to perform skin self-checks and engage in sun
protection behaviors.
PRIMARY OBJECTIVES:
I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin
self-examination (SSE) and sun protection behaviors among individuals diagnosed with
melanoma.
SECONDARY OBJECTIVES:
I. To examine mediators of the impact of the intervention. The effects of the intervention on
SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for
SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors,
perceived barriers to SSE and sun protection behaviors, and perceived controllability of
melanoma.
TERTIARY OBJECTIVES:
I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects
are moderated by the following factors: time since diagnosis, disease stage, age, sex,
income, education, Internet experience, distress about melanoma, worry about recurrence, and
evaluation and usage of the ITW.
OUTLINE:
Phase I: Patients review draft website content materials in a semi-structured format and
provide feedback via open- and closed-ended questions for the development, testing, and
finalization of ITW.
Phase II: Patients are randomized into 1 of 2 arms.
ARM I: Patients access ITW and complete each module over 30-40 minutes.
ARM II: Patients receive usual care and are then offered ITW.
All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin
self-examination (SSE) and sun protection behaviors among individuals diagnosed with
melanoma.
SECONDARY OBJECTIVES:
I. To examine mediators of the impact of the intervention. The effects of the intervention on
SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for
SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors,
perceived barriers to SSE and sun protection behaviors, and perceived controllability of
melanoma.
TERTIARY OBJECTIVES:
I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects
are moderated by the following factors: time since diagnosis, disease stage, age, sex,
income, education, Internet experience, distress about melanoma, worry about recurrence, and
evaluation and usage of the ITW.
OUTLINE:
Phase I: Patients review draft website content materials in a semi-structured format and
provide feedback via open- and closed-ended questions for the development, testing, and
finalization of ITW.
Phase II: Patients are randomized into 1 of 2 arms.
ARM I: Patients access ITW and complete each module over 30-40 minutes.
ARM II: Patients receive usual care and are then offered ITW.
All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Inclusion Criteria:
- Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase I: From 3-36 months post-surgical treatment
- Phase I: Access to the internet
- Phase I: Able to speak and read English
- Phase I: Able to provide informed consent
- Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase II: From 3-24 months post-surgical treatment
- Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at
least once during the past 2 months)
- Phase II: Not adherent to sun protection recommendations (i.e., mean score < 4 [which
corresponds to "often"] on a 5-point scale [from 1 = "never" to 5 = "always"] that
assesses the frequency of engaging in four sun protection behaviors)
- Phase II: Access to a computer connected to the internet
- Phase II: Able to speak and read English
- Phase II: Able to provide informed consent
We found this trial at
2
sites
Charlottesville, Virginia 22903
(434) 924-0311

Principal Investigator: Lee M. Ritterband, PhD
Phone: 434-924-5988
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
Click here to add this to my saved trials

New Brunswick, New Jersey 08903
Principal Investigator: Elliot J. Coups
Phone: 732-235-8076
Click here to add this to my saved trials
